Fortress Biotech, Inc. 13D and 13G filings for Avenue Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-06 4:31 pm Purchase | 2022-12-31 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 7,710 11.300% | 4,296 (+125.86%) | Filing |